<p>The Table shows the maximum TA tetanic force, EDL Motor Unit survival and Motor Neuron Survival in vehicle treated SOD1 and arimoclomol treated SOD1+A mice at 105 and 120 days of age. The results are the mean ± sem. **p<0.01.</p
<p>Kaplan-Meier survival curve shows that transgenic mice Sod1<sup>G93A</sup> (n = 7) treated with A...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>(A) Schedule for ASCs-E injection, behavior test, weight measure and brain sampling. (B) ASCs-E i...
<p>Effect of oral treatment with 800 mg/kg/day ubiquinone<sub>10</sub>, ubiquinol<sub>10</sub> or ve...
<p>CGS treatment at 12 weeks of age significantly rescues motor neuron degeneration in SOD1 mice (A;...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(<b>A</b>) Typical examples of motor unit traces in the EDL muscle of a WT and a vehicle treated ...
<p>Kaplan-Meier survival plot showing the lifespan of the SOD1 Tg mice treated with vehicle (blue) o...
<p>(A) NeuN-stained cross-sections of the spinal cord at the level L3 to L5. Non-treated controls (S...
<p>(A) Erlotinib trends toward delay in the age of onset of weight loss. This effect approaches sign...
Lower motor function was evaluated in (A) plantar and (B) tibialis anterior (TA) muscles at 8–16 wee...
SOD1G93A mice were treated with 5-FU every two weeks starting at age of 70 days. In each graph, grou...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Kaplan-Meier survival curve shows that transgenic mice Sod1<sup>G93A</sup> (n = 7) treated with A...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>(A) Schedule for ASCs-E injection, behavior test, weight measure and brain sampling. (B) ASCs-E i...
<p>Effect of oral treatment with 800 mg/kg/day ubiquinone<sub>10</sub>, ubiquinol<sub>10</sub> or ve...
<p>CGS treatment at 12 weeks of age significantly rescues motor neuron degeneration in SOD1 mice (A;...
<p>Given are parameters for disease onset (A-C), and survival (D) for the SOD-1 (G93A) (n = 17) and ...
<p>Histograms from Kaplan-Meier analysis showing the duration of the early phase (A) and the end sta...
<p>Group average change from initial body weight (top panels) and neurological disease severity scor...
<p>(<b>A</b>) Typical examples of motor unit traces in the EDL muscle of a WT and a vehicle treated ...
<p>Kaplan-Meier survival plot showing the lifespan of the SOD1 Tg mice treated with vehicle (blue) o...
<p>(A) NeuN-stained cross-sections of the spinal cord at the level L3 to L5. Non-treated controls (S...
<p>(A) Erlotinib trends toward delay in the age of onset of weight loss. This effect approaches sign...
Lower motor function was evaluated in (A) plantar and (B) tibialis anterior (TA) muscles at 8–16 wee...
SOD1G93A mice were treated with 5-FU every two weeks starting at age of 70 days. In each graph, grou...
<p>(A) Control and MB-treated (3, 10, 30 and 100 mg oral per kg body weight per day) SOD1<sup>G93A</...
<p>Kaplan-Meier survival curve shows that transgenic mice Sod1<sup>G93A</sup> (n = 7) treated with A...
<p>The motor function and deterioration was evaluated by Rotarod (A, female mice; B, male mice). The...
<p>(A) Schedule for ASCs-E injection, behavior test, weight measure and brain sampling. (B) ASCs-E i...
DOI
Add to ORKG